新疆喀什地区某医院冠心病心力衰竭住院患者的调查

Retrospective analysis of inpatients with coronary chronic heart failure of a hospital in Kashi district of Xinjiang

目的:调查分析冠心病慢性心力衰竭患者的临床情况。方法:入选新疆喀什地区第二人民医院内二科2005年5月～2006年11月确诊的冠心病慢性心力衰竭住院病例163例,按有无心肌梗死分为冠心病有心肌梗死(A)组和冠心病无心肌梗死(B)组进行分析。结果:入选病例占同期总的冠心病心力衰竭住院病例的76.9%(163/212)。年龄45岁～89岁,平均年龄(65.60±8.50)岁。A组49例(30.1%),B组114例(69.9%),B组多于A组(χ2=25.920,P<0.01)。A组患者男性的比例多于B组,B组合并COPD比例多于A组。两组在合并糖尿病、高血压,以及心功能NYHA(Ⅲ+Ⅳ)、左心室舒张末期左室内径(LEDD)、左室射血分数(LVEF)≥45%和E/A≤1的比例的分布差异无统计学意义。A组应用洋地黄制剂、硝酸酯制剂、血管紧张素转换酶抑制剂、β-受体阻滞剂的比例高于B组。结论:冠心病住院患者以无心肌梗死型居多,但总体临床情况复杂,不论是何种类型,都应该给予足够的重视。

Objective：To investigate the clinical characteristic of inpatients with coronary chronic heart failure. Methods：AU data were taken from the hospitalized cases with chronic heart failure cause by coronary heart disease. The data were divided into 2 groups （ group A and B） according to with or without myocardial infarction. Results： One hundred and sixty - three cases were enrolled and the proportion of the cases to heart failure eases during that time was 76.9 % （ 163/212）. The age range was 45 -98 years old and the mean of age was （65.60 ± 8.50 ） years old. 49 （30. 1% ） cases were enrolled in group A and 114 （69.9%） cases were enrolled in group B. The cases of group B were more than that of group A （ X^2 = 25. 920, P 〈 0. 01 ）. The male cases in group A were more than that of group B. The cases with COPD in group B were more than that of group A. There no statistical significance in the proportion with diabetes meLlitus,hypertension,heart function（ Ⅲ ＋Ⅳ） ,left ventricle end - diastolic diameter（ LEDD）, left ventricle ejection fraction （LVEF） 〉 45 % and E,/A ≤ 1 between the 2 groups. The medications d digitalis, niL＇ides, angiotensin converting enzyme inhibitors （ ACEIs ） and β - blockers in group A were more than that of group B. Conclusions ： The major cases occupied all the coronary artery disease patients. The clinical conditions were severe and complicated. The patients should be regarded importantly without reference to any type of coronary heart disease.